Home  /  Resource Library  /  Rituximab with high‑dose methotrexate is effective and cost‑effective in newly diagnosed primary central nervous system lymphoma

Rituximab with high‑dose methotrexate is effective and cost‑effective in newly diagnosed primary central nervous system lymphoma